Agios Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 10 analysts polled by S&P Global, Agios Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $41.13. The average 1-year stock price forecast is 46.16% higher than the current stock price, while the lowest is $28 (-0.50%) and the highest is $60 (+113.22%).

Price Target: $41.13 (+46.16%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$28	$41.13	$38.5	$60
Change	-0.50%	+46.16%	+36.82%	+113.22%

Analyst Ratings

The average analyst rating for Agios Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	4	4	4	4	4	4
Buy	1	1	1	1	1	1
Hold	3	3	3	3	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	8	8	8	8	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Gregory Renza Truist Securities	Truist Securities	Strong Buy Maintains $39 → $36	Strong Buy	Maintains	$39 → $36	+27.93%	Apr 30, 2026
Greg Harrison B of A Securities	B of A Securities	Strong Buy Maintains $44 → $41	Strong Buy	Maintains	$44 → $41	+45.70%	Apr 21, 2026
Emily Bodnar HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $65 → $50	Strong Buy	Maintains	$65 → $50	+77.68%	Apr 20, 2026
Tessa Romero JP Morgan	JP Morgan	Hold Maintains $31 → $36	Hold	Maintains	$31 → $36	+27.93%	Apr 6, 2026
Salveen Richter Goldman Sachs	Goldman Sachs	Hold Maintains $28 → $32	Hold	Maintains	$28 → $32	+13.72%	Apr 1, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

127.24M

from 54.03M

135.51%

from 54.03M

Revenue Next Year

266.21M

from 127.24M

109.22%

from 127.24M

EPS This Year

-6.30

from -7.12

EPS Next Year

-4.98

from -6.30

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	14.24M	26.82M	36.50M	54.03M	127.24M	266.21M
Revenue Growth	-	-	88.36%	36.07%	48.03%	135.51%	109.22%
EPS	26.55	-4.23	-6.33	11.64	-7.12	-6.30	-4.98
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	12	12

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	173.9M	378.2M
Avg	127.2M	266.2M
Low	87.2M	127.7M

Revenue Growth

Revenue Growth	2026	2027
High	221.9%	197.2%
Avg	135.5%	109.2%
Low	61.4%	0.4%

EPS Forecast

EPS	2026	2027
High	-5.78	-3.99
Avg	-6.30	-4.98
Low	-7.00	-6.12

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.